• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定一种针对 H5N1 病毒基质蛋白(M1)的细胞内人源化单链抗体。

Characterization of an intracellular humanized single-chain antibody to matrix protein (M1) of H5N1 virus.

机构信息

College of Life Science, Jilin Agricultural University, Changchun, China.

Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

出版信息

PLoS One. 2022 Mar 31;17(3):e0266220. doi: 10.1371/journal.pone.0266220. eCollection 2022.

DOI:10.1371/journal.pone.0266220
PMID:35358257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8970388/
Abstract

We developed a human intracellular antibody based on the M1 protein from avian influenza virus H5N1 (A/meerkat/Shanghai/SH-1/2012) and then characterized the properties of this antibody. The M1 protein sequence was amplified by RT-PCR using the cDNA of the H5N1 virus as a template, expressed in bacterial expression system BL21 (DE3) and purified. A human strain, high affinity, and single chain antibody (HuScFv) against M1 protein was obtained by phage antibody library screening using M1 as an antigen. A recombinant TAT-HuScFv protein was expressed by fusion with the TAT protein transduction domain (PTD) gene of HIV to prepare a human intracellular antibody against avian influenza virus. Further analysis demonstrated that TAT-HuScFv could inhibit the hemagglutination activity of the 300 TCID50 H1N1 virus, thus providing preliminary validation of the universality of the antibody. After two rounds of M1 protein decomposition, the TAT-HuScFv antigen binding site was identified as Alanine (A) at position 239. Collectively, our data describe a recombinant antibody with high binding activity against the conserved sequences of avian influenza viruses. This intracellular recombinant antibody blocked the M1 protein that infected intracellular viruses, thus inhibiting the replication and reproduction of H5N1 viruses.

摘要

我们基于 H5N1 禽流感病毒(A/猫鼬/上海/SH-1/2012)的 M1 蛋白开发了一种人类细胞内抗体,并对该抗体的特性进行了表征。使用 H5N1 病毒的 cDNA 作为模板,通过 RT-PCR 扩增 M1 蛋白序列,在细菌表达系统 BL21(DE3)中表达并纯化。通过使用 M1 作为抗原的噬菌体抗体文库筛选,获得了针对 M1 蛋白的人类高亲和力单链抗体(HuScFv)。通过融合 HIV 的 TAT 蛋白转导结构域(PTD)基因表达重组 TAT-HuScFv 蛋白,制备针对禽流感病毒的人类细胞内抗体。进一步分析表明,TAT-HuScFv 可以抑制 300 TCID50 H1N1 病毒的血凝活性,从而初步验证了该抗体的通用性。经过两轮 M1 蛋白分解,鉴定出 TAT-HuScFv 抗原结合位点为 239 位的丙氨酸(A)。综上所述,我们的数据描述了一种针对禽流感病毒保守序列具有高结合活性的重组抗体。这种细胞内重组抗体可阻断感染细胞内病毒的 M1 蛋白,从而抑制 H5N1 病毒的复制和繁殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/886a75a5d13d/pone.0266220.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/b4d796ef9d18/pone.0266220.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/aca224dd7467/pone.0266220.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/55330116fb14/pone.0266220.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/4cceb9672d50/pone.0266220.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/3420179bf930/pone.0266220.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/886a75a5d13d/pone.0266220.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/b4d796ef9d18/pone.0266220.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/aca224dd7467/pone.0266220.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/55330116fb14/pone.0266220.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/4cceb9672d50/pone.0266220.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/3420179bf930/pone.0266220.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fb/8970388/886a75a5d13d/pone.0266220.g006.jpg

相似文献

1
Characterization of an intracellular humanized single-chain antibody to matrix protein (M1) of H5N1 virus.鉴定一种针对 H5N1 病毒基质蛋白(M1)的细胞内人源化单链抗体。
PLoS One. 2022 Mar 31;17(3):e0266220. doi: 10.1371/journal.pone.0266220. eCollection 2022.
2
Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication.与人源单克隆 ScFv 结合不同功能域的 M2 和抑制 H5N1 流感病毒复制。
Virol J. 2013 May 14;10:148. doi: 10.1186/1743-422X-10-148.
3
Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes.可识别异源甲型流感病毒亚型基质蛋白的人源单链单克隆抗体。
J Virol Methods. 2009 Jul;159(1):105-11. doi: 10.1016/j.jviromet.2009.03.010. Epub 2009 Mar 20.
4
[Subcloning of M1 gene fragment of H5N1 influenza virus and its expression in Escherichia coli].H5N1流感病毒M1基因片段的亚克隆及其在大肠杆菌中的表达
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Aug;25(4):254-7.
5
A human single chain transbody specific to matrix protein (M1) interferes with the replication of influenza A virus.一种针对基质蛋白(M1)的人源单链转体可干扰甲型流感病毒的复制。
Bioconjug Chem. 2010 Jul 21;21(7):1134-41. doi: 10.1021/bc900251u.
6
Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.针对禽流感H5N1血凝素蛋白的单克隆抗体的产生与特性分析
Monoclon Antib Immunodiagn Immunother. 2015 Dec;34(6):436-41. doi: 10.1089/mab.2015.0047.
7
Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.甲型流感病毒神经氨酸酶N1亚型:免疫生物学特性及特异性抗体反应的功能检测
PLoS One. 2016 Apr 7;11(4):e0153183. doi: 10.1371/journal.pone.0153183. eCollection 2016.
8
[Preparation and characterization the polyclonal antibody of the nonstructural protein of human highly pathogenic H5N1 avian influenza viruses].[人高致病性H5N1禽流感病毒非结构蛋白多克隆抗体的制备与鉴定]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013 Apr;27(2):138-40.
9
Development and preliminary application of an indirect ELISA for detecting antibodies against Avian Influenza Virus.鸡流感病毒抗体间接 ELISA 的建立及初步应用
Res Vet Sci. 2012 Oct;93(2):710-5. doi: 10.1016/j.rvsc.2011.12.010. Epub 2012 Jan 9.
10
Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.用H5N1和甲型H1N1大流行性流感病毒的重组神经氨酸酶蛋白免疫引发的交叉反应性神经氨酸酶抑制抗体。
J Virol. 2015 Jul;89(14):7224-34. doi: 10.1128/JVI.00585-15. Epub 2015 May 6.

本文引用的文献

1
T cell mediated immunity against influenza H5N1 nucleoprotein, matrix and hemagglutinin derived epitopes in H5N1 survivors and non-H5N1 subjects.H5N1幸存者和非H5N1受试者中针对甲型流感病毒H5N1核蛋白、基质蛋白和血凝素衍生表位的T细胞介导免疫。
PeerJ. 2021 Mar 10;9:e11021. doi: 10.7717/peerj.11021. eCollection 2021.
2
Novel single-chain antibodies against highly conserved epitopes in the hemagglutinin of influenza A viruses: Promising agents for universal therapies.针对甲型流感病毒血凝素中高度保守表位的新型单链抗体:通用疗法的有望药物。
Iran J Basic Med Sci. 2021 Jan;24(1):17-23. doi: 10.22038/ijbms.2020.43508.10219.
3
Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice.
蛋白转导结构域介导的流感 NP 亚单位疫苗在小鼠中产生强烈的免疫应答和抗流感病毒保护作用。
Emerg Microbes Infect. 2020 Dec;9(1):1933-1942. doi: 10.1080/22221751.2020.1812436.
4
Dynamics of Influenza A (H5N1) virus protein sequence diversity.甲型流感病毒(H5N1)蛋白质序列多样性的动态变化
PeerJ. 2020 May 27;7:e7954. doi: 10.7717/peerj.7954. eCollection 2020.
5
Isolation of Neutralizing Human Single Chain Antibodies Against Conserved Hemagglutinin Epitopes of Influenza a Virus H3N2 Strain.针对甲型流感病毒H3N2株保守血凝素表位的人源中和单链抗体的分离
Rep Biochem Mol Biol. 2019 Oct;8(3):301-309.
6
Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain.通过霍乱毒素 A1 亚单位与蛋白转导结构域的重组融合开发安全且非自身免疫原性的黏膜佐剂。
J Immunol Res. 2018 Mar 7;2018:9830701. doi: 10.1155/2018/9830701. eCollection 2018.
7
The role of nuclear NS1 protein in highly pathogenic H5N1 influenza viruses.核 NS1 蛋白在高致病性 H5N1 流感病毒中的作用。
Microbes Infect. 2017 Dec;19(12):587-596. doi: 10.1016/j.micinf.2017.08.011. Epub 2017 Sep 10.
8
The ecology and adaptive evolution of influenza A interspecies transmission.甲型流感病毒种间传播的生态学与适应性进化
Influenza Other Respir Viruses. 2017 Jan;11(1):74-84. doi: 10.1111/irv.12412. Epub 2016 Aug 8.
9
Development of single-chain variable fragments (scFv) against influenza virus targeting hemagglutinin subunit 2 (HA2).针对流感病毒血凝素亚基2(HA2)的单链可变片段(scFv)的研发。
Arch Virol. 2016 Jan;161(1):19-31. doi: 10.1007/s00705-015-2625-6. Epub 2015 Oct 8.
10
Therapeutic applications of the TAT-mediated protein transduction system for complex I deficiency and other mitochondrial diseases.TAT介导的蛋白质转导系统在治疗复合体I缺乏症及其他线粒体疾病中的应用
Ann N Y Acad Sci. 2015 Sep;1350:17-28. doi: 10.1111/nyas.12858. Epub 2015 Aug 14.